bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.299
-0.004 (-1.40%)
Nov 21, 2024, 11:39 AM EST - Market open
bluebird bio Employees
bluebird bio had 375 employees as of December 31, 2023. The number of employees increased by 52 or 16.10% compared to the previous year.
Employees
375
Change (1Y)
52
Growth (1Y)
16.10%
Revenue / Employee
$141,653
Profits / Employee
-$780,867
Market Cap
58.10M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Atara Biotherapeutics | 225 |
Xtant Medical Holdings | 215 |
Champions Oncology | 210 |
Exagen | 179 |
Boundless Bio | 72 |
Immuneering | 68 |
enVVeno Medical | 31 |
Cellectar Biosciences | 20 |
BLUE News
- 1 day ago - My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys - Seeking Alpha
- 5 days ago - JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options - Benzinga
- 7 days ago - bluebird bio, Inc. (BLUE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance - Business Wire
- 14 days ago - bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call - Business Wire
- 16 days ago - bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition - Business Wire
- 6 weeks ago - Bluebird Bio (BLUE) Stock Dips Amid Market Volatility - GuruFocus
- 6 weeks ago - Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma - Seeking Alpha